Pancreatic cancer has the worst survival of any human cancer, and tumours are known to be extremely aggressive with minimal response to conventional systemic therapy.
In 2019, Dr Rachael Bashford-Rogers and Dr Shivan Sivakumar launched PancrImmune: the Oxford Pancreatic Network, which brings together the experimental, clinical and statistical expertise from across the Oxford ecosystem to investigate the immune microenvironment of pancreatic pathologies and plan novel therapeutic strategies for improving patient outcome.
Across the network, there are researchers and clinicians pioneering work across 12 core themes to truly understand the pancreas, how it causes such significant but varying diseases, and unlock the potential to treat pancreatic cancer.
For updates on the research and clinical trial outcomes of this work, please see the news section of the website.
PancrImmune is funded by grants including the Wellcome Trust.
PancrImmune includes researchers and clinicians from across the University departments, focusing on 12 core themes.
The network is coordinated and lead by a core team, read more about each of their work through the profiles below.